Delivery Order SPE2DB20D9103-SPE2DB23FE7B8

Award Date 2/28/23
Potential Completion Date 3/21/23
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,307.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,560 units of the NEXPLANON 68 MG IMPLANTS contraceptive device, with a period of performance through March 15, 2023. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with...
This is a $6,291.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,556,217,484 units of the contraceptive implant NEXPLANON 68 MG and has a completion date of February 28, 2022. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $25,167.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,557,562,613 units of the NEXPLANON 68 MG implants, a contraceptive device. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999, which enables the DLA to issue firm fixed-price orders for a comprehensive...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $12,864.42 to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,257,903 units of the contraceptive implant NEXPLANON 68 MG by May 1, 2024. This delivery order is part of a larger five-year indefinite delivery, indefinite quantity (IDIQ) contract, SPE2DB24D9238|SPE2DB24FDQDS, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 contract is for the delivery of 68 mg NEXPLANON implants, a contraceptive device. This delivery order is placed under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a comprehensive range of pharmaceutical products,...
This is a $2,858.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the procurement of 4,566,523 units of the Nexplanon 68 mg implant, a long-acting reversible contraceptive device. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This is a $5,717.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the procurement of 4,564,764,375 units of the contraceptive implant Nexplanon 68 mg, with a period of performance through June 14, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
This is a $4,165.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 68 mg NEXPLANON implants, a contraceptive device. The delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $5,033.44 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,557,298,149 units of the Nexplanon 68 mg implant, a contraceptive device. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which covers a wide range of branded and generic...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,414.65 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 4,566,904,770 units of NEXPLANON 68 MG implants, a contraceptive device, with a period of performance through January 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which allows...
  • SPE2DB20D9103
    Indefinite Delivery Contract
  • SPE2DB20D9103-SPE2DB23FE7B8
    Delivery Order

This is a $8,204.88 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,560,136,203 units of the NEXPLANON 68 MG IMPLANTS contraceptive device. This delivery order is placed under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 2/27/25, 12:06 PM